Jonathan Javitt
2022
In 2022, Jonathan Javitt earned a total compensation of $873.7K as Chief Scientist and former Chief Executive Officer at NRX Pharmaceuticals, a 132% increase compared to previous year.
Compensation breakdown
| Salary | $867,446 |
|---|---|
| Other | $6,250 |
| Total | $873,696 |
Javitt received $867.4K in salary, accounting for 99% of the total pay in 2022.
Javitt also received $6.3K in other compensation.
Rankings
In 2022, Jonathan Javitt's compensation ranked 3,321st out of 5,756 executives tracked by ExecPay. In other words, Javitt earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,321 out of 5,756 | 42nd |
Division Manufacturing | 1,872 out of 3,133 | 40th |
Major group Chemicals And Allied Products | 892 out of 1,419 | 37th |
Industry group Drugs | 835 out of 1,320 | 37th |
Industry Pharmaceutical Preparations | 609 out of 966 | 37th |
Source: SEC filing on November 22, 2023.
Javitt's colleagues
We found six more compensation records of executives who worked with Jonathan Javitt at NRX Pharmaceuticals in 2022.
2022
Ira Strassberg
NRX Pharmaceuticals
Chief Financial Officer
2022
Stephen Willard
NRX Pharmaceuticals
Chief Executive Officer
2022
Robert Besthof
NRX Pharmaceuticals
Chief Executive Officer
2022
Alessandra Daigneault
NRX Pharmaceuticals
General Counsel
2022
Seth Van Voorhees
NRX Pharmaceuticals
Chief Financial Officer
2022
Riccardo Panicucci
NRX Pharmaceuticals